CIK 0001810182
- Non-accelerated filer
- Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 850642577
- Phone
- +1 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-11 | Graham G. Walmsley Director | Grant or award · Stock option (right to buy) | +12,004 | 12,004 | ||
| 2020-12-14 | Graham G. Walmsley Director | Purchase | +20,000 | $76.00 | $1.5M | 995,000 |
| 2020-07-21 | Graham G. Walmsley Director | Conversion | +2,105,901 | 2,161,981 | ||
| 2020-07-21 | Graham G. Walmsley Director | Purchase | +975,000 | $19.00 | $18.5M | 975,000 |
| 2020-07-21 | Graham G. Walmsley Director | Conversion · Series C Convertible Preferred Stock | −2,105,901 | 0 | ||
| 2020-07-16 | Graham G. Walmsley Director | Grant or award · Stock Option (right to buy) | +24,009 | 24,009 |
Page 1 of 1 · 6 trades